Australian Early-Late Phase Clinical Trials

Breaking News! Health minister visits Linear to announce new funding from the government for Linear’s personalised cancer trials. Click below to learn more

Linear Cancer Trials

Other Trials

As Featured on:

Take it to market sooner

Our world-class early-phase and late-phase clinical trial and research capabilities will give you the clinical data and insights you need to realise your therapy’s medical and commercial potential sooner.

Why choose Linear?

Join our extended research team. Collaborate with us.

We’re at the heart of a global network of clinical researchers and medical innovators, and you can be part of it.

Find out more

Why Australia and Perth?

Did you know, Australian (TGA) clinical trial start-ups are typically 4-6 months faster than US (FDA) trials! Better still, they’re much cheaper – often a third of the cost and exceptional quality. And with our concept-to-commercialisation capabilities, we can compress those timeframes and costs even further.

No IND required
Fast-tracked approvals
Generous R&D refunds
Population: 2.2m
Asian time zone
Excellent health system
Access to patient databases
Data accepted by FDA, EMA, CFDA & PDMA
Diverse population

More about Australia & Perth

Why Linear?

From actively expediting clinical trial start-ups and recruitment, through to providing the data, insights and services you need to successfully go to market, our world-class end-to-end clinical research capabilities will get you there faster.

More about our advantage

20,000+ volunteers in our database
Close links with state health department
Vast medical and collaborator network
State-of-the-art 32-bed facility (expanding up to 40)
One of Australia’s largest health precincts
On-site CRA monitoring rooms and lab
On-site pharmacy, medical and QA resources
Experienced in complex, first-in-human studies
(over 145 trials completed)
Live quality control

“We’ll work with you to assess and realise the full medical and commercial value of your work, sharing our insights and network of partners to drive your therapy or product to fruition, swiftly and safely.”

Dr. Michael Winlo MBBS(Hons), MBA Chief Executive Officer, Linear

What our clients say

Linear was an outstanding partner for our phase one programs – always professional and willing to go the extra mile.

Steve Gourlay CMO Principia, San Francisco, USA

The phase one study we conducted with Linear was intricate, intensive and novel. Despite these challenges, the Linear team was impressive in its professionalism and commitment to delivering results and ensuring the study was a success.

Craig Cook Midatech, Oxfordshire, UK

Linear not only paid great attention to our project, but also worked hard to establish and maintain great working relationships … We look forward to working with Linear on more projects in the near future.

Xu Ning Zai Labs, Shanghai, China

Take it to market sooner

Join our extended research team. Collaborate with us.

Why Australia and Perth?

Why Linear?

Dr. Michael Winlo MBBS(Hons), MBA Chief Executive Officer, Linear

What our clients say

Please select your language preference

About us

Services and capabilities